Ann 8-year-old boy is described with borderline cognitive impairment, cerebellar hypoplasia,, a stroke-like episode, and venous thrombosis of the left leg after a period of immobilization.. The pattern of multiple abnormalities in blood coagulation suggested carbohydrate-deficientt glycoprotein syndrome type la. Isoelectric focusing of serum transferrinn was abnormal. The activity of phosphomannomutase in leucocytes and fibroblastss was decreased. Mutation analysis of the PMM2 gene revealed the R141H/E151GG genotype. These results confirm the presence of carbohydrate-deficient glycoproteinn syndrome type la without severe psychomotor retardation.
Introduction n
Carbohydrate-deficientt glycoprotein syndromes are genetic disorders affecting multiple organn systems, first described by Jaeken et al in 1980 . The characteristic biochemical featuree consists of hypoglycosylation of glycoproteins, readily demonstrated by isoelectric focusingg of serum transferrin.
: Four basic defects have been identified: phosphomannomutasee (PMM) deficiency' (EC 5.4.2.8.) , phosphomannoisomerase deficiency 4 "" (EC 5.3.1.8.) . deficient glucosylation of the dolichol-linked oligosaccharide 7 , andd N-acetyl-glucosaminyltransferase II deficiency" (EC 2.4.1.143) . The most common is CDGG syndrome type la, which is caused by PMM deficiency. The gene coding for PMM iss on chromosome lop.
1
' The clinical variability of CDG syndrome type la is broad, comprisingg severe mental deficiency, dysmorphism, cerebellar hypoplasia, and coagulation disturbances. .
Thiss report expands the spectrum of CDG syndrome type la with the description off an affected patient with borderline cognitive dysfunction and absent external dysmorphism. .
Casee report
Thee patient is an 8-year-old son of non-consanguineous white parents, born at term after a normall pregnancy. His birth weight was 3250 g. No dysmorphism was observed, especiallyy no inverted nipples and no fat pads. Length growth followed the 50th percentile, andd weight evolution was between 3rd and 10th percentiles. Examination at 9 months revealedd bilateral convergent strabismus with intact range of eye movements on lateral rotation,, spasmus nutans, hand dysmetria, and titubation. Cranial computed tomography scann demonstrated cerebellar hypoplasia. At 16 months, he propelled himself by shuffling. Att 18 months, he was able to stand with hand support, and he had adequate balancing reactionss but displayed postural tremor. Eye pursuit at the time was slow with nystagmus. Byy 22 months, he could walk without support but was ataxic. At the age of 2 years, receptivee language was adequate, but expressive language was delayed. A Reynell languagee test at 34 months showed receptive language (understanding) at the level of 39 monthss and general cognition at the level of 32 months. At 6 years of age. reading, writing,, and receptive and expressive language were considered appropriate for age by the school.. Formal intelligence testing at the age of 8 years disclosed full-scale IQ of 69, verball IQ of 75, and performance IQ of 68 (Wechsler Intelligence Scale for ChildrenRevised). Figure) . No signs of hematoma,, thrombosis, or infarction were present. He made a slow but full recovery and wass discharged after 10 days. Three months after the episode, the right hemisphere appearedd normal on brain magnetic resonance imaging. Figure. . T r weighted coronal magnetic resonancee imaging section of brain demonstratingg pancerebellar hypoplasia Threee weeks after discharge, he was readmitted because of a swollen painful left leg.. Ultrasonography confirmed the clinical suspicion of thrombosis of the left iliac and femorall veins. Treatment was initiated with standard heparin administered intravenously, followedd by oral anticoagulant therapy during 6 months. Plasma levels of coagulation factorr V (0.73 U/ml, normal range = 0.8-1.4 U/ml), factor VII (0.54 U/ml, normal range = 0.88 -1.4 U/ml). factor XI (0.34 U/ml, normal range = 0.5 -1.5 U/ml) and factor XII (0.4 U/ml,, normal range = 0.5 -1.5 U/ml) were decreased, as well as levels of coagulation inhibitorss antithrombin (0.49 U/ml, normal range = 0.8 -1.4 U/ml), protein C (0.26 U/ml, normall range = 0.65 -1.1 U/ml) and free protein S (0.23 U/ml. normal range = 0.26 -0.61 U/ml).. Both plasma levels of thrombin-antithrombin complex (11.4 |xg/L, normal range < 4.66 (xg/L) and prothrombin fragment 1 +2 ( 2.32 nmol/L, normal range = 0.3 -1.6 nmol/L)) were increased. Factor V R506Q mutation and factor II G20210A mutation were absentt and anti-phospholipid antibodies were not detectable. Because of the unexplained stroke-likee episode and the multiple abnormalities in blood coagulation, the diagnosis of CDGG syndrome was considered. Blood analysis showed an increased level of carbohydrate-deficientt transferrin of 125.3 U/L (control subjects, < 30 U/L), and isoelectricc focusing of serum transferrin revealed a marked increase of asialo-and disialotransferrinn (type 1 pattern). PMM activity, as described by Van Schaftingen and Jaeken', wass decreased in leucocytes (0.5 nmol/mg.min, control subjects [n=10] = 2.5 0.4 nmol/mg.min)) and in fibroblasts (Table) , confirming the diagnosis of CDG syndrome type la.. Mutation screening by single-stranded conformational polymorphism analysis and by sequencingg showed a combination of the R141H and E151G mutation. Table. . Phosphomannomutase activity in fibroblasts from the patient described in this report, a patientt with "classical" type la, and healthy control subjects The neurological features are age-related. Hypotonia, muscularr weakness, developmental retardation, and alternating esotropia and hyporeflexia cann be observed in the neonatal and infantile periods. After infancy, motor skills develop slowly.. Most children can sit without support at the age of 2 years and move independentlyy by shuffling. After the age of 2 to 4 years they are able to stand with support,, but only very few patients learn to walk. Muscular atrophy progresses slowly. Tendonn reflexes in the lower limbs cannot be elicited after the first 2 to 3 years of life. Cerebellarr ataxia and coordination difficulties are common findings. Contractures graduallyy develop. Stroke-like episodes occur, sometimes in combination with infections, afterr the age of 4 to 5 years. Retinitis pigmentosa will develop after 3 to 8 years. Mental developmentt is retarded and reaches a median IQ of 40 to 60. The main neuroradiologyfindingg is cerebellar hypoplasia, which is present in most of the patients."
Non-neurologicall features that can be present are slight facial dysmorphism, abnormall subcutaneous fat distribution ("peau d'orange"), inverted nipples, mild hepatomegalyy and hypogonadism. Some patients have pericardial effusions and/or cardiomyopathy.
14 '' Most of the multi-organ manifestations are present in the infantile periodd and appear to regress during childhood.
Bloodd coagulation disorders are a common feature of CDG syndrome type la. Thee most constant findings are reduced activities of antithrombin, protein C, and factor XI.. ' Decreased protein S activity is found less frequently. Although all coagulation factorss and inhibitors are glycoproteins, they are not equally affected. The degree of coagulationn factor and/or inhibitor deficiency varies among patients and can be severe or mild. .
Inn our patient, cerebellar ataxia and a stroke-like episode causing temporary hemiparesiss were the most prominent neurological symptoms. In contrast to previously reportedd patients with CDG syndrome type la, in this patient cognitive dysfunction was borderlinee and motor retardation was minor, mainly caused by ataxia. Lack of severe psychomotorr retardation led to the delay in diagnosis.
Venouss thrombosis has been reported in at least 3 patients with CDG syndrome typee la.
: " :: One patient had bilateral iliac and pelvic vein thrombosis after 3 weeks of immobilisationn for cerebral concussion." Plasma levels of antithrombin and protein C activityy were decreased. Our patient also had venous thrombosis after immobilisation. His bloodd coagulation analysis showed decreased plasma levels of antithrombin. protein C, andd free protein S. causing increased thrombin generation as measured by elevated thrombin-antithrombinn complex and prothrombin fragment 1+2. In general, venous thrombosiss in childhood has multiple causes, and more than 2 laboratory or clinical risk factorss are often required to precipitate thrombosis.
: ' Thus primary prophylactic anticoagulantt therapy for a certain period may be considered in patients with CDG syndromee type la and decreased coagulation inhibitors, especially when additional risk factorss for venous thrombosis are present.
Mutationn analysis revealed the R141H / E151G genotype. The R141H substitutionn is the most frequent mutation in CDG type la patients. 24 It is suggested that R14IHH is a severe mutation caused by lack of homozygotes for R141H. :4 The E151G mutationn has not been described before. E151G is conserved between PMM1 and PMM2. Fungall phosphomannomutases show ahistidine at this position, suggesting that E151G mightt give rise to the mild phenotype as demonstrated in our patient.
:? However, little is knownn about the relation between the genotype and the clinical phenotype of patients with CDGG type la patients.
CDGG syndrome type la should be ruled out in children with cerebellar hypoplasiaa and/or multiple coagulation disturbances, even in the absence of severe psychomotorr retardation and external dysmorphism. fibroblastss and I. Postma from the Department of Psychology of Emma Children's Hospitall AMC for performing the Wechsler Intelligence Scale for Children-Revised test in thee patient.
